Results for tag: "Liposarcoma Drug"

Liposarcoma is a rare type of cancer that affects the fatty tissues of the body. It is the most common type of soft tissue sarcoma, accounting for about 15% of all sarcomas. Treatment for liposarcoma typically involves surgery, radiation therapy, and chemotherapy. Oncology drugs are used to treat cancer, including liposarcoma. These drugs can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the side effects of other treatments. The liposarcoma drug market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of liposarcoma, the development of new drugs, and the increasing demand for personalized treatments. Companies in the liposarcoma drug market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more